Xvivo Perfusion AB Vs. Hansa Biopharma AB Industry Stock Comparison

Buy

68

XVIPF
Xvivo Perfusion AB

Last Price:

42.90

Seasonality Move:

-0.87%

Sell

39

HNSBF
Hansa Biopharma AB

Last Price:

2.83

Seasonality Move:

-3.19%

Buy

68

Xvivo Perfusion AB (XVIPF) is a Buy

Is Xvivo Perfusion AB a Buy, Sell or Hold?

The current Xvivo Perfusion AB [XVIPF] share price is $42.90. The Score for XVIPF is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
XVIPF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

39

Hansa Biopharma AB (HNSBF) is a Sell

Is Hansa Biopharma AB a Buy, Sell or Hold?

The current Hansa Biopharma AB [HNSBF] share price is $2.83. The Score for HNSBF is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
HNSBF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XVIPF Stock Price Chart

What is Xvivo Perfusion AB's stock price today?

The Xvivo Perfusion AB share price today is $42.90
The current trend is relatively stagnant and XVIPF is experiencing slight buying pressure.

HNSBF Stock Price Chart

What is Hansa Biopharma AB's stock price today?

The Hansa Biopharma AB share price today is $2.83
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HNSBF is experiencing slight buying pressure.

XVIPF Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.13	Sell
Relative Strength Index (14 RSI):	50.27	Buy
Chaikin Money Flow:	0	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(41.41 - 42.93)	Buy
Bollinger Bands (100):	(43.16 - 49.68)	Sell

HNSBF Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.19	Sell
Relative Strength Index (14 RSI):	8.68	Sell
Chaikin Money Flow:	0	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(3.01 - 3.77)	Sell
Bollinger Bands (100):	(2.8 - 3.48)	Sell

XVIPF Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	42.9	Sell
20-day SMA:	42.31	Buy
50-day SMA:	43.86	Sell
200-day SMA:	40.73	Buy
8-day EMA:	42.83	Buy
20-day EMA:	42.71	Buy
50-day EMA:	43.73	Sell
200-day EMA:	40.89	Buy

HNSBF Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	2.83	Sell
20-day SMA:	3.32	Sell
50-day SMA:	3.35	Sell
200-day SMA:	3.05	Sell
8-day EMA:	2.94	Sell
20-day EMA:	3.18	Sell
50-day EMA:	3.27	Sell
200-day EMA:	3.64	Sell

Xvivo Perfusion AB Earnings Growth & XVIPF Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Hansa Biopharma AB Earnings Growth & HNSBF Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Xvivo Perfusion AB Technical Analysis

	Dec 2	Dec 3	Dec 4	Dec 5	Dec 6	Dec 9	Dec 10	Dec 11	Dec 12	Dec 13
	Dec
	02	03	04	05	06	09	10	11	12	13
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Hansa Biopharma AB Technical Analysis

	Dec 2	Dec 3	Dec 4	Dec 5	Dec 6	Dec 9	Dec 10	Dec 11	Dec 12	Dec 13
	Dec
	02	03	04	05	06	09	10	11	12	13
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):